Literature DB >> 2101487

Oral administration of TNP-Lactobacillus conjugates in mice: a model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli.

K Gerritse1, M Posno, M M Schellekens, W J Boersma, E Claassen.   

Abstract

Safe live vector systems are being developed for oral delivery of antigens. A transformation system for indigenous Lactobacillus species of the gastrointestinal tract is described. Model systems were set up to evaluate immune responses. Orally administered trinitrophenylized (TNP) Lactobacillus were examined for their ability to induce immunological memory formation via determination of specific antibody titres in serum. We demonstrate a direct correlation between the level of systemic memory formation, as revealed by specific anti-TNP IgG serum antibodies, and the TNP substitution ratio of the Lactobacillus suspension used for oral priming. The specific IgG anti-TNP serum titres were comparable to or even higher than the titres of parental intraperitoneally primed animals. These results demonstrate the feasibility of using orally administered antigen-Lactobacillus as a future approach to vaccination.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2101487     DOI: 10.1016/0923-2508(90)90135-d

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  9 in total

Review 1.  Lactic acid bacteria as vaccine delivery vehicles.

Authors:  J M Wells; K Robinson; L M Chamberlain; K M Schofield; R W Le Page
Journal:  Antonie Van Leeuwenhoek       Date:  1996-10       Impact factor: 2.271

2.  Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production.

Authors:  C Hessle; L A Hanson; A E Wold
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli.

Authors:  D M Shaw; B Gaerthé; R J Leer; J G Van Der Stap; C Smittenaar; M Heijne Den Bak-Glashouwer; J E Thole; F J Tielen; P H Pouwels; C E Havenith
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

Review 4.  Mucosal immunity: an overview and studies of enteric and respiratory coronavirus infections in a swine model of enteric disease.

Authors:  L J Saif
Journal:  Vet Immunol Immunopathol       Date:  1996-11       Impact factor: 2.046

Review 5.  Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.

Authors:  Vafa Shahabi; Paulo C Maciag; Sandra Rivera; Anu Wallecha
Journal:  Bioeng Bugs       Date:  2010-01-04

6.  Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut.

Authors:  K E Shroff; K Meslin; J J Cebra
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.

Authors:  Praveen Mannam; Kevin F Jones; Bruce L Geller
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

8.  In vitro antioxidant, antibacterial, in vivo immunomodulatory, antitumor and hematological potential of exopolysaccharide produced by wild type and mutant Lactobacillus delbureckii subsp. bulgaricus.

Authors:  Bukola Adebayo-Tayo; Racheal Fashogbon
Journal:  Heliyon       Date:  2020-02-03

Review 9.  Adjuvant Strategies for Lactic Acid Bacterial Mucosal Vaccines.

Authors:  Allison C Vilander; Gregg A Dean
Journal:  Vaccines (Basel)       Date:  2019-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.